@article{JTD33284,
author = {Mahbub Jamil and Ibrahim Sultan and Thomas G. Gleason and Forozan Navid and Michael A. Fallert and Matthew S. Suffoletto and Arman Kilic},
title = {Infective endocarditis: trends, surgical outcomes, and controversies},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {11},
year = {2019},
keywords = {},
abstract = {The number of hospitalizations and surgical cases of infective endocarditis (IE) are increasing. The aim of this study was to review these trends, surgical outcomes, and controversies related to IE. A search of MEDLINE of studies published between 1960 and 2018 was conducted. Search terms included “infective endocarditis”, “history of”, “trend”, “epidemiology”, “outcome”, “medical management”, “surgery”, “indication”, and “re-operative surgery”, or any combination thereof. The United States has the highest incidence of IE in the world at 15 per 100,000 people, with increases in incidence due to the aging population as well as increasing rates of intravenous drug use (IVDU). National guidelines support early surgical intervention in specific clinical settings in both left and right-sided IE. However, only 11% of the evidence used in formulating guidelines for surgical therapy in IE are based on level A evidence. Ongoing controversies include whether to perform surgery in the setting of continued or recurrent IVDU in a patient with a prior valve operation, timing of surgery after acute stroke due to IE, and general indications for surgery for tricuspid valve IE. IE has a surging incidence and increasing burden on the healthcare system in the United States. Multiple controversies exist, and formulating level A evidence and multidisciplinary collaboration will be essential components to effectively treating this complex patient population.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/33284}
}